A2Aadenosine receptor-mediated inhibition of renal injury and neutrophil adhesion
- 1 November 2000
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 279 (5) , F809-F818
- https://doi.org/10.1152/ajprenal.2000.279.5.f809
Abstract
We sought to determine the mechanisms responsible for the reduced renal tissue injury by agonists of A2A adenosine receptors (A2A-ARs) in models of ischemia-reperfusion (I/R) injury. DWH-146e, a selective A2A-AR agonist, was administered subcutaneously to Sprague-Dawley rats and C57BL/6 mice via osmotic minipumps, and animals were subjected to I/R. I/R led to an increase in plasma creatinine and kidney neutrophil infiltration. Infusion of DWH-146e at 10 ng · kg−1 · min−1 produced a 70% reduction in plasma creatinine as well as a decrease in neutrophil density in outer medulla and cortex and myeloperoxidase activity in the reperfused kidney. Myeloperoxidase activity in kidney correlated with the degree of renal injury. P-selectin and intercellular adhesion molecule 1 (ICAM-1) immunoreactivity were most prominent in endothelial cells of peritubular capillaries and interlobular arteries of cortex and outer and inner medulla of vehicle-treated mice whose kidneys were subjected to I/R. DWH-146e treatment led to a pronounced decrease in P-selectin- and ICAM-1-like immunoreactivity. These data are consistent with our hypothesis that A2A-AR agonists limit I/R injury due to an inhibitory effect on neutrophil adhesion.Keywords
This publication has 37 references indexed in Scilit:
- α-Melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophilsKidney International, 1998
- Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.Journal of Clinical Investigation, 1997
- Management of acute renal failure: New perspectivesAmerican Journal of Kidney Diseases, 1996
- Distribution of ?2C-adrenergic receptor-like immunoreactivity in the rat central nervous systemJournal of Comparative Neurology, 1996
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Mild renal ischemia activates primed neutrophils to cause acute renal failureKidney International, 1992
- MALA‐2, mouse homologue of human adhesion molecule ICAM‐1 (CD54)European Journal of Immunology, 1989
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982